Corporate Presentation 1 Safe Harbor Statement 2 This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and assumptions and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These statements are based on the ...

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q3 2020 Earnings Conference Call November 9, 2020 8:30 AM ET Company Participants Juan Sanchez - Vice President, Corporate Communications and Investor Relations Sharon Mates - Chairman and Chief Executive Officer Mark Neumann - Chief Commercial Officer Suresh Durgam - Chief Medical Officer Larry Hineline - Chief Financial Officer Conference Call Participants Jessica Fye - JP Morgan Charles Duncan - Cantor Fitzgerald Sumant Kulkarni - Canaccord Bo Chen - Evercore ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36274 INTRA-CELLULAR THERAPIES, INC. (Exact name of registrant as specified in its charter) Delaware 36-4 ...

Corporate Presentation September 2020 1 Safe Harbor Statement 2 This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and assumptions and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These statements ar ...

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q2 2020 Earnings Conference Call August 10, 2020 8:30 AM ET Company Participants Juan Sanchez - Vice President, Corporate Communications & Investor Relations Sharon Mates - Chairman & Chief Executive Officer Mark Neumann - Executive Vice President & Chief Commercial Officer Andrew Satlin - Executive Vice President & Chief Medical Officer Larry Hineline - Senior Vice President & Chief Financial Officer Conference Call Participants Leo Timashev - RBC Capital Market ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36274 INTRA-CELLULAR THERAPIES, INC. (Exact name of registrant as specified in its charter) Delaware 36-474285 ...

Corporate Presentation June 2020 1 Safe Harbor Statement 2 This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and assumptions and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These statements are bas ...

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2020 Results Conference Call May 7, 2020 8:30 AM ET Company Participants Dr. Juan Sanchez - VP, Corporate Communications and IR Dr. Sharon Mates - Chairman and CEO Dr. Andrew Satlin - EVP and Chief Medical Officer Mark Neumann - EVP and Chief Commercial Officer Larry Hineline - EVP and CFO Conference Call Participants Charles Duncan - Cantor Fitzgerald Jessica Fye - JP Morgan Bo Chen - Evercore ISI Sumant Kulkarni - Canaccord Marc Goodman - SVB Leerink Brian A ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36274 INTRA-CELLULAR THERAPIES, INC. (Exact name of registrant as specified in its charter) Delaware 36-47428 ...

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2019 Earnings Conference Call March 2, 2020 8:30 AM ET Company Participants Juan Sanchez - VP, Corporate Communications & IR Sharon Mates - Co-Founder, Chairman, CEO & President Mark Neumann - EVP & Chief Commercial Officer Andrew Satlin - EVP & Chief Medical Officer Lawrence Hineline - SVP, Finance, CFO, Treasurer and Assistant Secretary Conference Call Participants Charles Duncan - Cantor Fitzgerald Marc Goodman - SVB Leerink Umer Raffat - Evercore Jessica F ...